# Precision Optics Corporation, Inc.: Form 10-Q for the period ended Dec 31, 2024

- Company: [Precision Optics Corporation, Inc.](/companies/poci.md) (CIK 867840)
- Form: 10-Q
- Filed: 2025-02-13
- Accepted by EDGAR: Feb 13, 2025, 16:15 ET
- Period: 2024-12-31
- Accession: 0001683168-25-000995
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/867840/000168316825000995/poci_i10q-123124.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/867840/000168316825000995/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-10-01 to 2024-12-31 | $4.5m | us-gaap:Revenues |
| Revenue | 6 months, 2024-07-01 to 2024-12-31 | $8.7m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2024-10-01 to 2024-12-31 | $3.5m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2024-07-01 to 2024-12-31 | $6.5m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2024-10-01 to 2024-12-31 | $1.1m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2024-07-01 to 2024-12-31 | $2.2m | us-gaap:GrossProfit |
| Research and development | 3 months, 2024-10-01 to 2024-12-31 | $317.7k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2024-07-01 to 2024-12-31 | $718.4k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2024-10-01 to 2024-12-31 | $1.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2024-07-01 to 2024-12-31 | $3.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2024-10-01 to 2024-12-31 | −$910.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2024-07-01 to 2024-12-31 | −$2.2m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2024-10-01 to 2024-12-31 | −$969.7k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2024-07-01 to 2024-12-31 | −$2.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-10-01 to 2024-12-31 | −$0.15 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2024-07-01 to 2024-12-31 | −$0.36 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-10-01 to 2024-12-31 | −$0.15 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2024-07-01 to 2024-12-31 | −$0.36 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-10-01 to 2024-12-31 | 6,350,403 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2024-07-01 to 2024-12-31 | 6,283,516 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2024-07-01 to 2024-12-31 | −$1.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2024-07-01 to 2024-12-31 | $54.2k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2024-12-31 | $212.4k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $7.8m | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $17.5m | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $6.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $8.0m | us-gaap:Liabilities |
| Long-term debt | at 2024-12-31 | $1.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2024-12-31 | $427.8k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2024-12-31 | $9.5m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/867840/000168316825000995/poci_i10q-123124.htm

Filed Feb 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001683168-25-000995. Last ingested by Listed: Oct 30, 2026, 16:26 ET. No prices; not investment advice.
